These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 16544963

  • 1. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial.
    Basnyat B, Gertsch JH, Holck PS, Johnson EW, Luks AM, Donham BP, Fleischman RJ, Gowder DW, Hawksworth JS, Jensen BT, Kleiman RJ, Loveridge AH, Lundeen EB, Newman SL, Noboa JA, Miegs DP, O'Beirne KA, Philpot KB, Schultz MN, Valente MC, Wiebers MR, Swenson ER.
    High Alt Med Biol; 2006; 7(1):17-27. PubMed ID: 16544963
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.
    Basnyat B, Gertsch JH, Johnson EW, Castro-Marin F, Inoue Y, Yeh C.
    High Alt Med Biol; 2003; 4(1):45-52. PubMed ID: 12713711
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
    van Patot MC, Leadbetter G, Keyes LE, Maakestad KM, Olson S, Hackett PH.
    High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912
    [Abstract] [Full Text] [Related]

  • 4. Low-dose acetylsalicylic acid analog and acetazolamide for prevention of acute mountain sickness.
    Kayser B, Hulsebosch R, Bosch F.
    High Alt Med Biol; 2008; 9(1):15-23. PubMed ID: 18331216
    [Abstract] [Full Text] [Related]

  • 5. Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial.
    Hillenbrand P, Pahari AK, Soon Y, Subedi D, Bajracharya R, Gurung P, Lal BK, Marahatta R, Pradhan S, Rai D, Sharma S, Birmingham Medical Research Expeditionary Society.
    Wilderness Environ Med; 2006; 17(2):87-93. PubMed ID: 16805144
    [Abstract] [Full Text] [Related]

  • 6. Reduced Acetazolamide Dosing in Countering Altitude Illness: A Comparison of 62.5 vs 125 mg (the RADICAL Trial).
    McIntosh SE, Hemphill M, McDevitt MC, Gurung TY, Ghale M, Knott JR, Thapa GB, Basnyat B, Dow J, Weber DC, K Grissom C.
    Wilderness Environ Med; 2019 Mar; 30(1):12-21. PubMed ID: 30630671
    [Abstract] [Full Text] [Related]

  • 7. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m).
    Carlsten C, Swenson ER, Ruoss S.
    High Alt Med Biol; 2004 Mar; 5(1):33-9. PubMed ID: 15072715
    [Abstract] [Full Text] [Related]

  • 8. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
    Gertsch JH, Basnyat B, Johnson EW, Onopa J, Holck PS.
    BMJ; 2004 Apr 03; 328(7443):797. PubMed ID: 15070635
    [Abstract] [Full Text] [Related]

  • 9. Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans.
    Basnyat B, Hargrove J, Holck PS, Srivastav S, Alekh K, Ghimire LV, Pandey K, Griffiths A, Shankar R, Kaul K, Paudyal A, Stasiuk D, Basnyat R, Davis C, Southard A, Robinson C, Shandley T, Johnson DW, Zafren K, Williams S, Weiss EA, Farrar JJ, Swenson ER.
    High Alt Med Biol; 2008 Apr 03; 9(3):209-16. PubMed ID: 18800957
    [Abstract] [Full Text] [Related]

  • 10. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness.
    Lipman GS, Jurkiewicz C, Winstead-Derlega C, Navlyt A, Burns P, Walker A, Phillips C, Reilly A, Burnier A, Romero J, Warner K, Hackett P.
    High Alt Med Biol; 2019 Sep 03; 20(3):271-278. PubMed ID: 31259608
    [Abstract] [Full Text] [Related]

  • 11. Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group).
    Basnyat B, Holck PS, Pun M, Halverson S, Szawarski P, Gertsch J, Steif M, Powell S, Khanal S, Joshi A, Shankar R, Karambay J, Alexander HD, Stone A, Morrissey C, Thompson BH, Farrar J, SPACE Trial Group.
    Wilderness Environ Med; 2011 Mar 03; 22(1):15-22. PubMed ID: 21377114
    [Abstract] [Full Text] [Related]

  • 12. Acetazolamide for the prevention of acute mountain sickness--a systematic review and meta-analysis.
    Ritchie ND, Baggott AV, Andrew Todd WT.
    J Travel Med; 2012 Mar 03; 19(5):298-307. PubMed ID: 22943270
    [Abstract] [Full Text] [Related]

  • 13. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T, Browne V, Heileson HL, Wallace D, Anholm J, Green SM.
    Arch Intern Med; 2005 Feb 14; 165(3):296-301. PubMed ID: 15710792
    [Abstract] [Full Text] [Related]

  • 14. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
    Berger MM, Sareban M, Schiefer LM, Swenson KE, Treff F, Schäfer L, Schmidt P, Schimke MM, Paar M, Niebauer J, Cogo A, Kriemler S, Schwery S, Pickerodt PA, Mayer B, Bärtsch P, Swenson ER.
    J Appl Physiol (1985); 2022 Jun 01; 132(6):1361-1369. PubMed ID: 35511718
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic Acetaminophen or Ibuprofen Results in Equivalent Acute Mountain Sickness Incidence at High Altitude: A Prospective Randomized Trial.
    Kanaan NC, Peterson AL, Pun M, Holck PS, Starling J, Basyal B, Freeman TF, Gehner JR, Keyes L, Levin DR, O'Leary CJ, Stuart KE, Thapa GB, Tiwari A, Velgersdyk JL, Zafren K, Basnyat B.
    Wilderness Environ Med; 2017 Jun 01; 28(2):72-78. PubMed ID: 28479001
    [Abstract] [Full Text] [Related]

  • 16. Low-dose acetylsalicylic Acid analog and acetazolamide for prevention of acute mountain sickness.
    Basnyat B, Gertsch JH, Holck PC.
    High Alt Med Biol; 2008 Jun 01; 9(4):349; author reply 351-2. PubMed ID: 19115924
    [No Abstract] [Full Text] [Related]

  • 17. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis.
    Low EV, Avery AJ, Gupta V, Schedlbauer A, Grocott MP.
    BMJ; 2012 Oct 18; 345():e6779. PubMed ID: 23081689
    [Abstract] [Full Text] [Related]

  • 18. Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness.
    Leshem E, Caine Y, Rosenberg E, Maaravi Y, Hermesh H, Schwartz E.
    J Travel Med; 2012 Oct 18; 19(5):308-10. PubMed ID: 22943271
    [Abstract] [Full Text] [Related]

  • 19. A Randomized Controlled Trial of the Lowest Effective Dose of Acetazolamide for Acute Mountain Sickness Prevention.
    Lipman GS, Jurkiewicz C, Burnier A, Marvel J, Phillips C, Lowry C, Hawkins J, Navlyt A, Swenson ER.
    Am J Med; 2020 Dec 18; 133(12):e706-e715. PubMed ID: 32479750
    [Abstract] [Full Text] [Related]

  • 20. Budesonide Versus Acetazolamide for Prevention of Acute Mountain Sickness.
    Lipman GS, Pomeranz D, Burns P, Phillips C, Cheffers M, Evans K, Jurkiewicz C, Juul N, Hackett P.
    Am J Med; 2018 Feb 18; 131(2):200.e9-200.e16. PubMed ID: 28668540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.